Introduction：Basic information about CAS 1217709-85-7|Repaglinide D5, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Repaglinide D5 |
|---|
| CAS Number | 1217709-85-7 | Molecular Weight | 457.61700 |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | C27H31D5N2O4 | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | 4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]-2-(1,1,2,2,2-pentadeuterioethoxy)benzoic acid |
|---|
| Synonym | More Synonyms |
|---|
Repaglinide D5 BiologicalActivity
| Description | Repaglinide D5 (AG-EE 623ZW D5) is deuterium labeled Repaglinide. Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus[1]. |
|---|
| Related Catalog | Signaling Pathways >>Others >>OthersResearch Areas >>Metabolic Disease |
|---|
| In Vitro | Repaglinide reduces postprandial glucose levels by enhancing the early phase of insulin secretion and increasing the total amount of insulin secreted[1]. |
|---|
| References | [1]. Wang LC, et al. Characteristics of repaglinide and its mechanism of action on insulin secretion in patients with newly diagnosed type-2 diabetes mellitus.Medicine (Baltimore). 2018 Sep;97(38):e12476. |
|---|
Chemical & Physical Properties
| Molecular Formula | C27H31D5N2O4 |
|---|
| Molecular Weight | 457.61700 |
|---|
| Exact Mass | 457.29900 |
|---|
| PSA | 82.36000 |
|---|
| LogP | 6.12520 |
|---|
| InChIKey | FAEKWTJYAYMJKF-NTSVIFQKSA-N |
|---|
| SMILES | CCOc1cc(CC(=O)NC(CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O |
|---|
| Storage condition | -20°C |
|---|
Synonyms
| [2H5]-Repaglinide |
| Repaglinide-ethyl-d5 |
